Skip to main content
Category

Manufacturing

2023 Cell Therapy CDMO BenchmarkingManufacturing

2023 Cell Therapy CDMO Benchmarking

Industry Standard Research (ISR) takes pride in our suite of Quality Benchmarking work and this study is no exception. The inaugural Cell Therapy CDMO Benchmarking has a wealth of information, created with two goals in mind: (1) Help cell therapy…
2023 Gene Therapy CDMO Benchmarking ThumbnailManufacturing

2023 Gene Therapy CDMO Benchmarking

2023 Gene Therapy CDMO Benchmarking Industry Standard Research (ISR) takes pride in our suite of Quality Benchmarking work and this study is no exception. The inaugural Gene Therapy CDMO Benchmarking has a wealth of information, created with two goals in…
Manufacturing

How Industry Benchmarks Can Inform CDMO Selection

Biopharmaceutical sponsor considerations when selecting a CDMO may include timelines, cost, regulatory requirements, capacity, quality, risks, and previous experience. To help sponsors better understand and prioritize development and manufacturing elements, ISR conducts four annual, manufacturing-specific benchmark studies that ask professionals…
Five Steps to CDMO SelectionManufacturing

Five Steps to CDMO Selection

Sponsors will see success in their CDMO partnerships by dedicating time and effort to establish a plan that identifies outsourcing drivers, to select a model that matches company needs and resources, to establish a decision-making process and group, and to…
Manufacturing

Biologic Drug Product CDMO Benchmarking (5th Ed.)

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 23 performance attributes specific to outsourced drug product manufacturing.